Topical Tranexamic in Adult Spinal Deformity Surgery (TTADS): A Double-Blinded, Placebo Controlled Randomized Controlled Trial

Disclosure(s):

Han Jo Kim, MD: Acuity Surgical: Royalty Recipient (Ongoing); Alphatec Spine: Consultant (Ongoing); Aspen Medical: Consultant (Ongoing), Royalty Recipient (Ongoing); Blackstone: Consultant (Ongoing); Globus Medical: Stock Shareholder (excluding mutual funds) (Terminated, February 1, 2025); Highridge: Royalty Recipient (Ongoing); K2M / Stryker: Royalty Recipient (Ongoing); MiRus: Consultant (Ongoing); SI Bone: Consultant (Ongoing)